The emerging therapy of the medication represents a significant advance in the care of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide affects multiple pathways – GLP-1 and GIP – resulting in https://tirzepatide-peptide586248.blognody.com/51992765/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment